HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 207 filers reported holding HORIZON PHARMA PLC in Q2 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,197,000 | +27.5% | 158,800 | -5.8% | 0.23% | +6.9% |
| Q4 2018 | $3,292,000 | -24.1% | 168,500 | -24.0% | 0.22% | -21.5% |
| Q3 2018 | $4,340,000 | +36.8% | 221,678 | +15.7% | 0.28% | +1.5% |
| Q2 2018 | $3,173,000 | -72.6% | 191,578 | -75.9% | 0.27% | -77.6% |
| Q4 2017 | $11,593,000 | +87.8% | 794,062 | +63.2% | 1.21% | +87.5% |
| Q3 2017 | $6,173,000 | +27.6% | 486,463 | +19.4% | 0.65% | +12.9% |
| Q2 2017 | $4,836,000 | -34.4% | 407,398 | -18.3% | 0.57% | -41.8% |
| Q1 2017 | $7,372,000 | +1800.0% | 498,765 | +1978.2% | 0.98% | +1143.0% |
| Q4 2016 | $388,000 | -81.7% | 24,000 | -79.5% | 0.08% | -79.4% |
| Q3 2016 | $2,121,000 | +10.1% | 117,000 | 0.0% | 0.38% | +5.5% |
| Q2 2016 | $1,927,000 | -62.5% | 117,000 | -62.3% | 0.36% | -61.1% |
| Q1 2016 | $5,137,000 | – | 310,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |